Omalizumab in children with severe allergic disease: a case series

BACKGROUND: Currently, severe allergic asthma and food allergy in children represent an important public health problem with medical, psychosocial and economic impacts. Omalizumab is a humanized monoclonal anti-IgE antibody, approved for refractory allergic asthma and chronic urticaria. It has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Crisafulli, Giuseppe, Caminiti, Lucia, Chiera, Fernanda, Arasi, Stefania, Salzano, Giuseppina, Panasiti, Ilenia, Barbalace, Andrea, Pajno, Giovanni Battista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332555/
https://www.ncbi.nlm.nih.gov/pubmed/30642367
http://dx.doi.org/10.1186/s13052-019-0602-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332555/
https://www.ncbi.nlm.nih.gov/pubmed/30642367
http://dx.doi.org/10.1186/s13052-019-0602-5

Ejemplares similares